Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 15Rectal Neoplasms 14Colonic Neoplasms 14Stomach Neoplasms 10Ovarian Neoplasms 7Carcinoma, Hepatocellular 5Gastrointestinal Stromal Tumors 4Carcinoma, Renal Cell 4Peritoneal Neoplasms 3Pancreatic Neoplasms 3Liver Neoplasms 3Neoplastic Cells, Circulating 2Neoplasms 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Incontinence 1Surgical Wound Infection 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neuroendocrine Tumors 1Ovarian Cysts 1Obesity, Morbid 1Neoplasm Metastasis 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 44pembrolizumab 35Fluorouracil 32Capecitabine 31durvalumab 27Leucovorin 26lenvatinib 24Magnetic Resonance Spectroscopy 15Irinotecan 14Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11Drug Therapy 11pemigatinib 10apatinib 10Taxes 10Floxuridine 10130-nm albumin-bound paclitaxel 10Radiotherapy 9Bevacizumab 9S 1 (combination) 8Platinum 8Folfox protocol 8Carboplatin 81,2-diaminocyclohexaneplatinum II citrate 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholangiocarcinoma × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡